Embecta (EMBC) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Utah Medical Products (UTMD) has outperformed Embecta (EMBC) over the past year, gaining 18.4% versus a loss of 58.2%. Embecta is the larger company by market cap ($322.1 million vs $236.6 million), about 1.4 times the size. On valuation, Embecta trades at a lower trailing P/E (3.9x vs 22.7x for Utah Medical Products).
Embecta offers the higher dividend yield (8.09% vs 1.66%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMBC | UTMD |
|---|---|---|
| Share price | $5.69 | $74.54 |
| Market cap | $322.11M | $236.58M |
| 1-day change | -1.13% | +0.90% |
| YTD return | -52.15% | +33.20% |
| 1-year return | -58.17% | +18.45% |
| 5-year return | — | -17.20% |
| P/E ratio (TTM) | 3.87 | 22.73 |
| Forward P/E | 3.23 | — |
| EPS (TTM) | $1.47 | $3.28 |
| Dividend yield | 8.09% | 1.66% |
| Annual dividend | $0.46 | $1.24 |
| 52-week high | $14.91 | $76.89 |
| 52-week low | $2.77 | $53.66 |
| Distance from 52-week high | -61.87% | -3.06% |
| Analyst consensus | none | — |
| Avg. price target upside | -29.64% | — |
| Average volume | 1.37M | 34.56K |
| Shares outstanding | 56.66M | 3.17M |
| Employees | 1,850 | 140 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UTMD has outperformed EMBC by 76.6 percentage points over the past year.
- Utah Medical Products trades at a higher earnings multiple (22.7x vs 3.9x trailing P/E).
- Embecta offers a meaningfully higher dividend yield (8.09% vs 1.66%).
About Embecta
EMBC stock →Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Health Care · Medical/Dental Instruments · 1,850 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
EMBC vs UTMD FAQ
Which is bigger, Embecta or Utah Medical Products?
Embecta (EMBC) is larger, with a market capitalization of $322.11M compared with $236.58M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, EMBC or UTMD?
UTMD returned +18.45% over the past 12 months, compared with -58.17% for EMBC (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EMBC or UTMD?
EMBC has the lower trailing P/E at 3.9, versus 22.7 for UTMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Embecta or Utah Medical Products?
Embecta has the higher yield at 8.09%, compared with 1.66% for Utah Medical Products.
Are Embecta and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.